CCL2 and atherosclerosis: This was in line with the maintenance of increased plasma levels of pro-inflammatory cytokines critical to vascular inflammation and atherosclerosis progression (Boring et al., 1998; Boisvert et al., 2000; Tacke et al., 2007), notably the monocyte chemoattractant MCP-1, observed even at Day 28 (Figure 1C), in spite of its return to normal levels in the peritoneal cavity.